Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
Liqiang Feng, Qian Wang, Chao Shan, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 224

Showing 1-25 of 224 citing articles:

Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
Alice Cho, Frauke Muecksch, Dennis Schaefer-Babajew, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 517-522
Open Access | Times Cited: 274
Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial
Shipo Wu, Jianying Huang, Zhe Zhang, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 12, pp. 1654-1664
Open Access | Times Cited: 254
Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
Samir Andrade Mendonça, Réka Lőrincz, Paul Boucher, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 243
Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
Ian A. McDonald, Sam M. Murray, Catherine J. Reynolds, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 232
COVID-19: Coronavirus Vaccine Development Updates
Jing Zhao, Shan Zhao, Junxian Ou, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 212
Intranasal COVID-19 vaccines: From bench to bed
Aqu Alu, Li Chen, Lei Hong, et al.
EBioMedicine (2022) Vol. 76, pp. 103841-103841
Open Access | Times Cited: 208
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
Philip J. M. Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, et al.
Cell (2021) Vol. 184, Iss. 5, pp. 1188-1200.e19
Open Access | Times Cited: 181
A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate
Lorena Sanchez‐Felipe, Thomas Vercruysse, Sapna Sharma, et al.
Nature (2020) Vol. 590, Iss. 7845, pp. 320-325
Open Access | Times Cited: 173
A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters
Traci L. Bricker, Tamarand L. Darling, Ahmed O. Hassan, et al.
Cell Reports (2021) Vol. 36, Iss. 3, pp. 109400-109400
Open Access | Times Cited: 150
Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2
Tanushree Dangi, Jacob Class, Nicole Palacio, et al.
Cell Reports (2021) Vol. 36, Iss. 10, pp. 109664-109664
Open Access | Times Cited: 132
A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques
Ahmed O. Hassan, Friederike Feldmann, Haiyan Zhao, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 4, pp. 100230-100230
Open Access | Times Cited: 122
Vaccine delivery systems toward lymph nodes
Yingyue Ding, Zhaoting Li, Ana Jaklenec, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 113914-113914
Open Access | Times Cited: 116
Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities
Majed Ghattas, Garima Dwivedi, Marc Lavertu, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1490-1490
Open Access | Times Cited: 113
Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3
Yujing Fan, Kwok‐Hung Chan, Ivan Fan‐Ngai Hung
Vaccines (2021) Vol. 9, Iss. 9, pp. 989-989
Open Access | Times Cited: 109
Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status
Vivek P. Chavda, Rajashri Bezbaruah, Disha Valu, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 432-432
Open Access | Times Cited: 49
Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques
Katherine McMahan, Frank Wegmann, Malika Aïd, et al.
Nature (2023) Vol. 626, Iss. 7998, pp. 385-391
Open Access | Times Cited: 40
Neutralizing antibodies for the treatment of COVID-19
Shibo Jiang, Xiujuan Zhang, Yang Yang, et al.
Nature Biomedical Engineering (2020) Vol. 4, Iss. 12, pp. 1134-1139
Open Access | Times Cited: 112
Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes
Mina Kelleni
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110982-110982
Open Access | Times Cited: 100
Viral Vectors for COVID-19 Vaccine Development
Kenneth Lundström
Viruses (2021) Vol. 13, Iss. 2, pp. 317-317
Open Access | Times Cited: 85
A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes
Yu Guo, Lisu Huang, Guangshun Zhang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 85
Status Report on COVID-19 Vaccines Development
Arun Kumar, William E. Dowling, Raúl Gómez Román, et al.
Current Infectious Disease Reports (2021) Vol. 23, Iss. 6
Open Access | Times Cited: 78
Animal models for SARS‐CoV‐2 research: A comprehensive literature review
Kabita Pandey, Arpan Acharya, Mahesh Mohan, et al.
Transboundary and Emerging Diseases (2020) Vol. 68, Iss. 4, pp. 1868-1885
Open Access | Times Cited: 73
Review of COVID-19 viral vector-based vaccines and COVID-19 variants
Rachana Vanaparthy, Gisha Mohan, Deepa Vasireddy, et al.
Infezioni in Medicina (2021) Vol. 29, Iss. 3, pp. 328-338
Open Access | Times Cited: 73
An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates
Nerea Zabaleta, Wenlong Dai, Urja Bhatt, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 9, pp. 1437-1453.e8
Open Access | Times Cited: 69
Animal models for SARS-CoV-2
Chung-Young Lee, Anice C. Lowen
Current Opinion in Virology (2021) Vol. 48, pp. 73-81
Open Access | Times Cited: 65
Page 1 - Next Page

Scroll to top